RE:RE:RE:RE:RE:RE:Food For ThoughtI'm not buying a stock because they put out news. Viemed has held up on acquisitions because of the risk, when they are growing organically fine. One bad acquisition and you get hurt bad. If they buy a company with say 400 patients, you have no idea how long they will live. Viemed just bought Viemed on the cheap (share buyback). I have no idea if Quipt diversified because I don't follow the company. Viemed is licensed in at least 47 states if I remember. If you look at their job openings, you will see they are all over the country.
I'm not into buying revenue, and either is Viemed. I would like to see them make an acquisition, but not the wrong one. I also would like more news releases, but you can't have everything.
I just took a quick look at Quipt. They won't have earnings for a complete year until 2023.